Print PDF

Pharmaceutical Compliance Congress 2025

Policy Shifts Under the New Administration – Implications for Life Sciences
Estancia La Jolla, San Diego, CA
September 4-5, 2025

Unite with industry leaders to delve into regulatory shifts, enforcement trends and risk management guidance to fortify your compliance program.

Agenda

Partner Scott Liebman will be speaking on the panel "Policy Shifts Under the New Administration – Implications for Life Sciences" on September 4 from 9:45-10:30 AM.

Topics: 

  • Explore recent executive orders implemented by the new administration and resulting shifts in the regulatory and enforcement landscapes
  • Examine impact on the pharma/biotech/MedTech industry and discuss how compliance programs are reacting

Click here to register.

Attorneys

Practice Areas

Industries

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.